ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

YS YS Biopharma Company Ltd

1,02
0,00 (0,00%)
20 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
YS Biopharma Company Ltd YS NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 1,02 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,02 1,02
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/05/202408:30PRNUSYS Biopharma Announces Name Change to LakeShore Biopharma
21/05/202417:15PRNUSYS Biopharma Announces Results of Extraordinary General..
07/05/202417:20PRNUSYS Biopharma to Hold Extraordinary General Meeting on May..
29/04/202409:00PRNUSYS Biopharma Receives Additional 180 Day Extension by Nasdaq..
19/04/202408:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
18/04/202409:00PRNUSYS Biopharma Granted Phase I Clinical Trial License of..
16/04/202409:00PRNUSYS Biopharma to Report First Nine Months of Fiscal Year 2024..
09/04/202409:00PRNUSYS Biopharma Announces Positive Interim Results of Pivotal..
03/04/202409:00PRNUSYS Biopharma Announces Full Repayment of US$40,000,000 Loan..
05/03/202410:00PRNUSYS Biopharma Announces Board Changes and Strategic..
22/02/202419:00PRNUSYS Biopharma Announces Results of Extraordinary General..
18/02/202406:30PRNUS/C O R R E C T I O N -- YS Biopharma Co., Ltd./
16/02/202422:20PRNUSYS Biopharma Announces Results of Extraordinary General..
14/02/202410:00PRNUSYS Biopharma to Hold an Extraordinary General Meeting on..
14/02/202409:50PRNUSYS Biopharma Announces Appointment of New Directors
12/02/202410:50PRNUSYS Biopharma Responds to a Notice of Extraordinary General..
09/02/202408:30PRNUSYS Biopharma Announces US$40 Million Private Placement..
08/02/202420:10PRNUSShareholders of YS Biopharma Announce an Extraordinary..
22/01/202419:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
08/01/202410:00PRNUSYS Biopharma Announces Changes to its Board Committees
20/12/202318:30PRNUSYS Biopharma Responds to Unauthorized Press Release..
20/12/202310:56PRNUSYS Biopharma Co., Ltd. to Hold Extraordinary General Meeting..
14/11/202310:30PRNUSNoble Capital Markets Initiates Coverage on YS Biopharma..
31/10/202309:30PRNUSYS Biopharma Announces Completion of Subject Enrollment in..
26/10/202309:30PRNUSYS Biopharma Announces Receipt of Nasdaq Notice
26/09/202309:30PRNUSYS Biopharma Announces First Subject Enrollment in Pivotal..
15/09/202309:30PRNUSYS Biopharma Granted Patent in the U.S. for Immunotherapy..
05/09/202309:30PRNUSYS Biopharma to Participate in Participate in Citi's 18th..
24/08/202317:15PRNUSYS Biopharma Announces Purchase of Shares by Company..
15/08/202318:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
26/07/202318:00PRNUSYS Biopharma Announces Financial Results for Fiscal Year..
21/07/202317:30PRNUSYS Biopharma to Report Financial Results for Fiscal Year..

Seu Histórico Recente

Delayed Upgrade Clock